HF
EVH icon

HRT Financial’s Evolent Health EVH Stock Holding History

HRT Financial’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,726,196
Closed -$3.94M – 4544
2026
Q1 		$3.94M Buy
1,726,196
+1,029,519
+148% +$3.27M 0.01% 1151
2025
Q4 		$2.79M Buy
696,677
+294,626
+73% +$1.64M 0.01% 1090
2025
Q3 		$3.4M Buy
+402,051
New +$3.9M 0.01% 861
2025
Q1 		– Sell
-66,548
Closed -$748K – 2737
2024
Q4 		$748K Sell
66,548
-24,255
-27% -$426K ﹤0.01% 1239
2024
Q3 		$2.57M Buy
90,803
+29,625
+48% +$764K 0.01% 779
2024
Q2 		$1.17M Buy
61,178
+36,073
+144% +$921K 0.01% 953
2024
Q1 		$823K Buy
+25,105
New +$801K 0.01% 979
2022
Q4 		– Sell
-92,664
Closed -$3.33M – 2651
2022
Q3 		$3.33M Buy
+92,664
New +$3.26M 0.04% 413
2019
Q4 		– Sell
-13,424
Closed -$96K – 1288
2019
Q3 		$96K Buy
+13,424
New +$96.3K ﹤0.01% 1250

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

HRT Financial's EVH Position: Q2 2026 in Review

HRT Financial sold out of Evolent Health (EVH) in Q2 2026, closing a stake of 1,726,196 shares — an estimated $3.94M sold.

HRT Financial first reported a position in EVH in Q3 2019 and held it in 9 quarters. The position peaked at $3.94M in Q1 2026. 199 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • HRT Financial reported no remaining Evolent Health position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 1,726,196 Evolent Health shares in Q2 2026, an estimated $3.94M.
  • HRT Financial first reported a position in Evolent Health in Q3 2019 and held it in 9 quarters.
  • HRT Financial's Evolent Health position peaked at $3.94M in Q1 2026.
  • 199 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.